Atlas Trials

Galera Therapeutics, Inc.

17 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Galera Therapeutics, Inc.

RecordFirmDate
Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer (NCT04698915)Galera Therapeutics, Inc.2021-05-07
Phase I/II Study of SBRT and GC4711 for Centrally Located or Large NSCLC (NCT04476797)Galera Therapeutics, Inc.2020-10-18
A Trial of GC4419 in Patients With Critical Illness Due to COVID-19 (NCT04555096)Galera Therapeutics, Inc.2020-09-09
Ph 2 Open Label Study of GC4419 to Reduce SOM Associated With Chemoradiotherapy for Head and Neck Cancer (NCT04529850)Galera Therapeutics, Inc.2020-06-30
Effects of Intravenous GC4419 on the Incidence and Severity of Esophagitis Due to Chemoradiotherapy for Lung Cancer (NCT04225026)Galera Therapeutics, Inc.2019-12-19
Study to Evaluate the Effects of Renal Impairment on the Pharmacokinetics, Safety and Tolerability of GC4419 (NCT05412472)Galera Therapeutics, Inc.2019-04-04
A Study Designed to Evaluate the Safety and Pharmacokinetics of Intravenously Administered Superoxide Dismutase Mimetic GC4711 in Healthy Volunteers (NCT03762031)Galera Therapeutics, Inc.2019-03-19
Study to Evaluate the Effects of 90 mg Intravenous Infusions of GC4419 on the Single Dose Pharmacokinetics of Dextromethorphan in Healthy Adult Subjects (NCT03792971)Galera Therapeutics, Inc.2019-02-10
A Phase 1 Study of the Safety and Pharmacokinetics of GC4711 (Oral Capsule) Compared to GC4419 (IV Infusion) and GC4711 (IV Infusion) in Healthy Volunteers (NCT03099824)Galera Therapeutics, Inc.2018-10-16
ROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer Patients (NCT03689712)Galera Therapeutics, Inc.2018-10-03
Pilot Dose Escalation Trial of Stereotactic Body Radiation Therapy (SBRT) in Combination With GC4419 in Pancreatic Cancer (NCT03340974)Galera Therapeutics, Inc.2018-02-12
A Study Designed to Compare the Safety and Pharmacokinetics of Intravenously Administered Superoxide Dismutase Mimetic GC4711 and GC4419 in Healthy Volunteers (NCT03194139)Galera Therapeutics, Inc.2017-09-25

Track Galera Therapeutics, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.